- Blood cancer
- Childhood leukaemia
- Acute lymphoblastic leukaemia (ALL)
- Acute myeloid leukaemia (AML)
- Acute promyelocytic leukaemia (APL)
- Chronic lymphocytic leukaemia (CLL)
- Chronic myeloid leukaemia (CML)
- Chronic myelomonocytic leukaemia (CMML)
- Hairy cell leukaemia (HCL)
- Large granular lymphocytic leukaemia (LGLL)
- Plasma cell leukaemia (PCL)
- T-cell acute lymphoblastic leukaemia (T-ALL)
- Other conditions related to blood cancer
Acute promyelocytic leukaemia (APL)
APL is a type of blood cancer that affects blood-producing cells made in your bone marrow.
Worried about Coronavirus? Visit our Coronavirus hub for the latest information and advice.
Acute promyelocytic leukaemia (APL) happens when the promyelocytes (a type of blood cell) don’t fully develop and become cancerous. These cancerous cells collect inside the bone marrow, and there isn’t room for enough normal blood cells to be made. This leads to the symptoms of APL such as bruising and bleeding, infections and weight loss.
APL is a rare form of acute myeloid leukaemia (AML) - around 200 people in the UK find out they have APL every year.
APL can progress (develop) very quickly and people diagnosed with APL will start treatment immediately.
What is acute promyelocytic leukaemia (APL)?
Acute promyelocytic leukaemia (APL) is a form of cancer that affects blood-producing cells in the bone marrow. It occurs when these cells don’t mature properly and become cancerous. APL is a subtype of acute myeloid leukaemia (AML).
When you’re healthy and everything is working normally, the promyelocytes in your bone marrow mature and produce neutrophils (cells which fight infections).
In a person with APL, the promyelocytes don’t mature properly and become cancerous. These cancerous cells collect inside the bone marrow, which means there isn’t room for enough normal blood cells to be made. This is what causes most of the symptoms of APL.
All kinds of cancer involve changes in genes in the affected cells. The distinctive feature of APL is the presence of a faulty gene called PML/RARA. Almost all people with APL (around 99% of cases) have this faulty gene in their leukaemia cells.
The PML/RARA gene is caused by parts of two chromosomes (chromosomes 15 and 17) swapping over. This is called a translocation. When you are being diagnosed, your doctors will look at the chromosomes in your bone marrow to check for this translocation.
What causes APL?
In many cases, we still don’t know what causes APL. There are no known environmental factors which have been proven to increase the risk of getting APL. You may have a slightly increased risk of getting APL if you’ve been treated for a different cancer or if you’ve received chemotherapy for another condition in the past.
You can get APL at any age. It’s slightly less common in children under 10, but otherwise the likelihood of developing APL is roughly the same across all age groups.
APL is equally common in men and women.
We don’t know of any reported evidence of APL running in families. Occasionally, there are cases where another family member may also have leukaemia or another type of blood cancer, but the cause of this may not be inherited.
Receiving treatment for other cancers
A very small number of patients can develop APL after being treated for another cancer or treatment with chemotherapy for another condition. This type of APL is called treatment related APL (tAPL) and can be caused by certain types of chemotherapy or radiotherapy.
More than half of all cases of tAPL occur in people who have previously been treated for breast cancer, but the overall risk of developing tAPL is still very low. The risk of developing tAPL is highest in the three years after the treatment for the previous cancer.
The treatment for tAPL is generally the same as for other forms of APL, although your specialist may choose to use a different drug in this situation.